We are live on ! Find out more
ACIU icon

AC Immune

48 hedge funds and large institutions have $163M invested in AC Immune in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 5

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

81% more capital inflows, than outflows

Capital inflows: $5.35M | Capital outflows: $2.96M

33% more funds holding

Funds holding: 36 → 48 (+12)

0.45% more ownership

Funds ownership: 27.81% → 28.26% (+0.45%)

27% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 15

Holders
48
Holders Change
+12
Holders Change %
+33.33%
% of All Funds
0.94%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
17
Increased
11
Reduced
15
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ACIU Hedge Fund Activity: Q4 2019 in Review

48 of the 5,095 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2019, worth a combined $163M — up 75% from $93M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ACIU positions and 5 closed out — a net gain of 12 holders — while 11 added to existing stakes and 15 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $1.16M. The largest seller was ALPS Advisors, exiting entirely with an estimated $667K sold.

  • 48 institutional investors held AC Immune (ACIU) as of Q4 2019, up from 36 in Q3 2019.
  • Funds reported $163M of AC Immune stock for Q4 2019, up 75% quarter-over-quarter.
  • 17 funds opened new AC Immune positions in Q4 2019 and 5 closed out, a net change of +12 holders.
  • The largest AC Immune buyer in Q4 2019 was Acadian Asset Management, an estimated $1.16M added.
  • The largest AC Immune seller in Q4 2019 was ALPS Advisors, an estimated $667K sold.

Based on aggregated 13F filings for Q4 2019.